Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

High-performing Natural Phytoactive Skincare for Sensitive Skin

Project description

Natural relief for chronic skin conditions

Chronic skin conditions such as psoriasis and eczema often remain inadequately addressed by conventional treatments, leaving sufferers in search of effective relief. These challenges are compounded by the limited availability of natural solutions that avoid harsh chemicals and additives. Patients frequently experience extreme dryness, itching, and inflammation, which can significantly impact their quality of life. In this context, the EU-funded Haloderma project specialises in extracting and analysing phytochemicals from halophytes – plants that thrive in saline conditions. Building on decades of research, the project aims to develop a potent natural skincare extract rich in antioxidants and polyphenols. Their prototype cream has already shown significant promise in alleviating symptoms of dermatitis, providing relief and visible improvement for users.

Objective

Haloderma is a spin-out company from Aalborg university. Our team is expert in halophytes phytochemicals extraction and analysis for skincare purpose. Prof. Mette Thomsen, the founder of Haloderma, has dedicated decades of her research to understand halophytes and their applications. Thanks to our state-of-the-art characterization methods, we are able to optimise our extraction process to formulate a natural herbal extract with strong potency for the skin. Our extract is designed for a rich composition of antioxidants, flavonoids and polyphenols targeted towards anti-inflammation and regeneration of the skin. Those abilities make our extract suitable for chronic skin issues such as psoriasis, eczema, urticaria. Some of the phytochemicals extracted have not been categorised in literature before, which makes our research innovative and unique. Today, Haloderma is solely focused on producing natural skincare for sensitive/damaged skin. Our prototype cream was described in a study analysing its effect against itch and pain caused by dermatitis. Current users of our cream suffered from issues of extreme dryness, psoriasis and chronic eczema. They unanimously reported relief from the first cream application and visual improvements of the skin were observed as early as 14 days after. We are ambitious in our mission to become the leading Danish phytoactive skincare business for problematic skin. Currently, more clinical studies need to be executed to fully understand the power and applications of our extract. Given the success of our cream, we plan to expand our product portfolio to a skincare line. We hereby apply to this Horizon grant to fulfil our product development steps towards high-performing natural phytoactive skincare products for sensitive skin.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

HALODERMA APS
Net EU contribution
€ 75 000,00
Address
NIELS BOHRS VEJ 6
6700 Esbjerg
Denmark
SME
Yes
Region
Danmark Syddanmark Sydjylland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data